Skip to content
WeighLab
Menu
Ranked #205 · Grade C

Kina review

Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

Visit Kina Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$179/mo (starting dose, plus a separate fee, compounded)
Tirzepatide
$179/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$2,148

Tirzepatide · modeled / year

$2,148

The Index scorecard

Kina scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month61/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight88/100
Contract Flexibility61/100

Where the value is

  • Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
  • Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
  • Verifiable LegitScript certification (seal ID 50917967)
  • GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
  • Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake

The tradeoffs

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Built for women navigating menopause — less tailored if that is not your situation
  • A separate $50 physician consultation fee applies on top of the medication price
  • The compounding pharmacy partner is not named, and the full list of served states is not published

The bottom line

Best for: Cost-first shoppers who want women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians. Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

Ranked #205 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Kina.

The 18 programs nearest this one

Pricing, states and verification reflect Kina's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Kina's site. Not medical advice; see our disclosure.

← Back to the value leaderboard